Study Exclusion reasons Remarks Reference(s)
O'Brien (Part B: recently infected asymptomatic patients), 2021 randomized controlled trial

O'Brien MP et al. medrxiv;2021.06.14.21258569v1 10.1101/2021.06.14.21258569